Smith & Nephew plc Stock Rating Reaffirmed by Morgan Stanley (SNN)
Smith & Nephew plc (NYSE:SNN) traded up 0.10% during mid-day trading on Monday, hitting $89.50. The stock had a trading volume of 138,154 shares. Smith & Nephew plc has a one year low of $57.99 and a one year high of $100.90. The stock’s 50-day moving average is $89.2 and its 200-day moving average is $80.81. The company has a market cap of $16.003 billion and a P/E ratio of 30.78.
Smith & Nephew plc (NYSE:SNN) last issued its quarterly earnings data on Friday, August 1st. The company reported $1.02 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.94 by $0.08. On average, analysts predict that Smith & Nephew plc will post $4.14 earnings per share for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Smith & Nephew plc in a research note on Monday. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Smith & Nephew plc in a research note on Monday. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Smith & Nephew plc in a research note on Monday. Eight equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Smith & Nephew plc has an average rating of “Buy” and a consensus target price of $97.00.
Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (NYSE:SNN) and advanced wound management.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.